Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001140361-25-041137·Aimei Health Technology Co., Ltd.
Schedule 13G ownership disclosure
AIMEI HEALTH TECHNOLOGY CO
Ordinary Shares, par value $0.0001 per share · CUSIP: G01341109
Event date: 2025-11-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- WOLVERINE ASSET MANAGEMENT LLC
Shares: 0 · Class: 0%
- Wolverine Trading Partners, Inc.
Shares: 0 · Class: 0%
- Wolverine Holdings, L.P.
Shares: 0 · Class: 0%
- Christopher L. Gust
Shares: 0 · Class: 0%
- Robert R. Bellick
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-25-041137
- Form type
- SCHEDULE 13G/A
- Filer
- Aimei Health Technology Co., Ltd.
- CIK
- CIK 1979005
- Filed
- Nov 07, 2025
- Reporting period
- Nov 03, 2025
- Description
- Schedule 13G beneficial ownership